SELECTIVE TARGETING OF FCRN AND IGG CLEARANCE BY NIPOCALIMAB PRESERVES KEY IMMUNE FUNCTIONS

Autor: LE Ling, S Tyler, CJ Beneduce, F Yu, J Brown, S Kumar, R Xu, J Duffner, AB Perdomo, W Avery

Publikováno v: Hematology, Transfusion and Cell Therapy. 44:S13

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64f385ec41b0b659baeb25597ed27a67
https://doi.org/10.1016/j.htct.2022.09.022

AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics.

Autor: Antonioli M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Albiero F; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Nazio F; Dulbecco Telethon Institute at the Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy; Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy., Vescovo T; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Perdomo AB; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Corazzari M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Marsella C; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Piselli P; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Gretzmeier C; Department of Dermatology, University Freiburg Medical Center, 79104 Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, 79104 Freiburg, Germany., Dengjel J; Department of Dermatology, University Freiburg Medical Center, 79104 Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, 79104 Freiburg, Germany., Cecconi F; Dulbecco Telethon Institute at the Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy; Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy; Unit of Cell Stress and Survival, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark., Piacentini M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy. Electronic address: mauro.piacentini@uniroma2.it., Fimia GM; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce 73100, Italy. Electronic address: gianmaria.fimia@inmi.it.

Publikováno v: Developmental cell [Dev Cell] 2014 Dec 22; Vol. 31 (6), pp. 734-46. Date of Electronic Publication: 2014 Dec 11.

Applying proteomic technology to clinical virology.

Autor: Mancone C; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Cellular Biotechnologies and Haematology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome. Electronic address: tripodi@bce.uniroma1.it., Ciccosanti F; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Montaldo C; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Cellular Biotechnologies and Haematology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome., Perdomo AB; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Piacentini M; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Alonzi T; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Fimia GM; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Tripodi M; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2013 Jan; Vol. 19 (1), pp. 23-28. Date of Electronic Publication: 2012 Oct 03.

Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome.

Autor: Perdomo AB; National Institute for Infectious Diseases IRCCS L. Spallanzani, Rome, Italy., Ciccosanti F, Iacono OL, Angeletti C, Corazzari M, Daniele N, Testa A, Pisa R, Ippolito G, Antonucci G, Fimia GM, Piacentini M

Publikováno v: Journal of proteome research [J Proteome Res] 2012 Feb 03; Vol. 11 (2), pp. 717-27. Date of Electronic Publication: 2011 Dec 07.

Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytes.

Autor: Mancone C; Laboratory of Gene Expression, National Institute for Infectious Diseases L. Spallanzani IRCCS, Via Portuense 292, Rome, Italy., Conti B, Amicone L, Bordoni V, Cicchini C, Calvo L, Perdomo AB, Fimia GM, Tripodi M, Alonzi T

Publikováno v: Journal of hepatology [J Hepatol] 2010 Feb; Vol. 52 (2), pp. 234-43. Date of Electronic Publication: 2009 Nov 25.